Investigator meeting · Dr. Sven Eriksen

28 Apr 2026 · Virtual · Dr. Sven Eriksen, Universitätsklinikum Heidelberg · MSL Dr. Anna Becker · Nephrada

ReviewedManualENG-0129—

Capture insight from this engagement

Location: Universitätsklinikum Heidelberg
Therapeutic area: Nephrology
Country: Germany
Stakeholder tier: Tier 2
Strategic objective: Not linked
Initiative: Not linked
MSL: ABDr. Anna BeckerMSL, Nephrology (DACH)
Product: Nephrada (nephradin)

Topics discussed

Patient-reported outcomes
Treatment burden and fatigue

Scientific content used

NPH mechanism-of-action deck

Questions raised

What is the immunoglobulin monitoring recommendation?

Notes

Investigator meeting with academic nephrologist at Universitätsklinikum Heidelberg. Discussed patient-reported outcomes, treatment burden and fatigue.

Insights captured (0)

Capture insight

No insights captured from this engagement.

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

Schedule follow-up in 6 weeks

0 of 1 complete

Quality ratings

1–5, rated at review

Scientific relevance: 3
Strategic relevance: 5
Depth of exchange: 5
Actionability: 1

Data lineage

Source system: Manual
Sync: Entered manually in Hub
System of record: Hub
Record id: ENG-0129

Audit history (0)

All create, update and approval events for this record

No audit events in sample data